EARNEST Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
EARNEST Partners's BSX Position: Q4 2023 in Review
EARNEST Partners sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 651 shares — an estimated $34.4K sold.
EARNEST Partners first reported a position in BSX in Q4 2016 and held it in 25 quarters. The position peaked at $35.2K in Q2 2023. 1,150 funds tracked by Wall St. Rank hold BSX as of Q4 2023.
- EARNEST Partners reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
- EARNEST Partners sold 651 Boston Scientific shares in Q4 2023, an estimated $34.4K.
- EARNEST Partners first reported a position in Boston Scientific in Q4 2016 and held it in 25 quarters.
- EARNEST Partners's Boston Scientific position peaked at $35.2K in Q2 2023.
- 1,150 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.
Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.